Drug Type Biological products |
Synonyms XXB 750, XXB-750, XXB750 |
Target |
Mechanism NPRA agonists(Natriuretic peptide receptor 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Failure | Phase 2 | US | 12 Dec 2023 | |
Heart Failure | Phase 2 | US | 12 Dec 2023 | |
Heart Failure | Phase 2 | CN | 12 Dec 2023 | |
Heart Failure | Phase 2 | JP | 12 Dec 2023 | |
Heart Failure | Phase 2 | BG | 12 Dec 2023 | |
Heart Failure | Phase 2 | CZ | 12 Dec 2023 | |
Heart Failure | Phase 2 | DK | 12 Dec 2023 | |
Heart Failure | Phase 2 | FR | 12 Dec 2023 | |
Heart Failure | Phase 2 | DE | 12 Dec 2023 | |
Heart Failure | Phase 2 | HU | 12 Dec 2023 |